Artivion, Inc. (AORT)
26.77
+0.10
(+0.38%)
USD |
NYSE |
Aug 28, 16:00
26.76
0.00 (0.00%)
After-Hours: 20:00
Artivion Free Cash Flow : -9.157M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.157M |
| March 31, 2026 | 14.58M |
| December 31, 2025 | 0.839M |
| September 30, 2025 | 15.75M |
| June 30, 2025 | 7.663M |
| March 31, 2025 | -0.439M |
| December 31, 2024 | 11.05M |
| September 30, 2024 | 11.00M |
| June 30, 2024 | 8.938M |
| March 31, 2024 | 11.04M |
| December 31, 2023 | 11.15M |
| September 30, 2023 | -0.401M |
| June 30, 2023 | -6.175M |
| March 31, 2023 | -22.03M |
| December 31, 2022 | -15.87M |
| September 30, 2022 | -14.83M |
| June 30, 2022 | -21.00M |
| March 31, 2022 | -16.19M |
| December 31, 2021 | -17.90M |
| September 30, 2021 | -12.75M |
| June 30, 2021 | -0.283M |
| March 31, 2021 | 0.404M |
| December 31, 2020 | 5.041M |
| September 30, 2020 | -0.042M |
| June 30, 2020 | 4.656M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.884M |
| December 31, 2019 | 7.755M |
| September 30, 2019 | 18.56M |
| June 30, 2019 | 14.97M |
| March 31, 2019 | 15.90M |
| December 31, 2018 | 4.095M |
| September 30, 2018 | -0.186M |
| June 30, 2018 | -5.829M |
| March 31, 2018 | -9.507M |
| December 31, 2017 | 4.171M |
| September 30, 2017 | 1.80M |
| June 30, 2017 | 6.978M |
| March 31, 2017 | 14.77M |
| December 31, 2016 | 13.52M |
| September 30, 2016 | 12.27M |
| June 30, 2016 | 9.18M |
| March 31, 2016 | 8.299M |
| December 31, 2015 | 7.952M |
| September 30, 2015 | 10.54M |
| June 30, 2015 | 8.253M |
| March 31, 2015 | 7.126M |
| December 31, 2014 | 3.808M |
| September 30, 2014 | 4.476M |
| June 30, 2014 | 9.213M |
| March 31, 2014 | 11.52M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alphatec Holdings, Inc. | -5.739M |
| Globus Medical, Inc. | 750.84M |
| Glaukos Corp. | -28.80M |
| TransMedics Group, Inc. | 79.04M |
| PROCEPT BioRobotics Corp. | -84.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.266M |
| Cash from Investing (Quarterly) | -129.41M |
| Cash from Financing (Quarterly) | 152.39M |
| Free Cash Flow Per Share (Quarterly) | -0.2475 |
| Free Cash Flow to Equity (Quarterly) | -161.82M |
| Free Cash Flow to Firm (Quarterly) | -3.638M |
| Free Cash Flow Yield | -0.70% |